NL140242B - Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen. - Google Patents
Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.Info
- Publication number
- NL140242B NL140242B NL646406089A NL6406089A NL140242B NL 140242 B NL140242 B NL 140242B NL 646406089 A NL646406089 A NL 646406089A NL 6406089 A NL6406089 A NL 6406089A NL 140242 B NL140242 B NL 140242B
- Authority
- NL
- Netherlands
- Prior art keywords
- oxazepines
- preparing
- basic group
- place substituted
- substituted dibenz
- Prior art date
Links
- 150000000221 oxazepines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D267/20—[b, f]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US262217A US3158623A (en) | 1963-03-01 | 1963-03-01 | 5-nitro-2-furylthioamide |
| CH1190763A CH450422A (de) | 1963-09-27 | 1963-09-27 | Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)(1,4)oxazepine |
| CH1646463 | 1963-09-27 | ||
| CH1646263 | 1963-09-27 | ||
| CH1646363 | 1963-09-27 | ||
| CH676263A CH436297A (de) | 1964-05-27 | 1964-05-27 | Verfahren zur Herstellung 11-basisch substituierter Dibenz(b, f)-(1,4)oxazepine |
| CH358267 | 1967-03-13 | ||
| CH410367A CH481133A (de) | 1967-03-22 | 1967-03-22 | Verfahren zur Herstellung basisch substituierter Heterocyclen |
| CH655767A CH484924A (de) | 1967-05-09 | 1967-05-09 | Verfahren zur Herstellung basisch substituierter Heterocyclen |
| CH1101567 | 1967-07-14 | ||
| CH1545367 | 1967-11-03 | ||
| US79728169A | 1969-02-06 | 1969-02-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL6406089A NL6406089A (nl) | 1964-12-01 |
| NL140242B true NL140242B (nl) | 1973-11-15 |
Family
ID=27582891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL646406089A NL140242B (nl) | 1963-03-01 | 1964-05-29 | Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen. |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US3546226A (nl) |
| NL (1) | NL140242B (nl) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3884920A (en) * | 1967-07-14 | 1975-05-20 | Sandoz Ag | 11-Basically substituted dibenz {8 b,f{9 {0 {8 1,4{9 {0 oxazepines |
| GB1192812A (en) * | 1966-05-20 | 1970-05-20 | American Cyanamid Co | 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts |
| GB1265866A (nl) * | 1968-08-23 | 1972-03-08 | ||
| GB1262509A (en) * | 1969-06-20 | 1972-02-02 | Science Union & Cie | New tricyclic derivatives and process for their preparation |
| CA918659A (en) * | 1969-07-31 | 1973-01-09 | Yoshitomi Pharmaceutical Industries | 11-(4-substituted-1-piperazinyl)-dibenzo (b,f) (1,4) thiazepines |
| BE754406A (fr) * | 1969-08-06 | 1971-02-04 | Wander Ag Dr A | Nouveaux derives de la dibenzo-oxazepine leur preparation et medicaments contenant ces derives |
| US3891647A (en) * | 1970-08-06 | 1975-06-24 | Wander Ag Dr A | 2-trifluoromethyl-sulphonyl-11-substituted-piperazinyl-dibenz {8 b,f{9 {8 1,4{9 {0 oxazepine |
| US4016273A (en) * | 1975-07-16 | 1977-04-05 | American Cyanamid Company | Sustained release forms of certain oxazepines for parenteral administration |
| CH624682A5 (nl) * | 1976-11-10 | 1981-08-14 | Sandoz Ag | |
| US5059600A (en) * | 1989-03-31 | 1991-10-22 | Yale University | Treating habit disorders |
| US5223497A (en) * | 1989-03-31 | 1993-06-29 | Yale University | Treating habit disorders |
| US5114942A (en) * | 1989-03-31 | 1992-05-19 | Yale University | Treating habit disorders |
| JPH04211071A (ja) * | 1990-03-05 | 1992-08-03 | Hokuriku Seiyaku Co Ltd | 多環式化合物 |
| US5538965A (en) * | 1993-12-23 | 1996-07-23 | Allelix Biopharmaceuticals Inc. | Dopamine receptor ligands |
| US5700445A (en) * | 1994-12-12 | 1997-12-23 | Allelix Biopharmaceuticals, Inc. | N-methyl piperazine compounds having dopamine receptor affinity |
| US5602121A (en) * | 1994-12-12 | 1997-02-11 | Allelix Biopharmaceuticals, Inc. | Alkyl-substituted compounds having dopamine receptor affinity |
| US5602120A (en) * | 1994-12-12 | 1997-02-11 | Allelix Biopharmaceuticals, Inc. | Benzyl-substituted compounds having dopamine receptor affinity |
| US5602124A (en) * | 1994-12-12 | 1997-02-11 | Allelix Biopharmaceuticals, Inc. | 5-HT2 receptor ligands |
| US5576314A (en) * | 1994-12-12 | 1996-11-19 | Allelix Biopharmaceuticals Inc. | Bicyclic nonane and decane compounds having dopamine receptor affinity |
| US5561127A (en) * | 1994-12-19 | 1996-10-01 | Allelix Biopharmaceuticals, Inc. | Muscarinic receptor ligands |
| US6271225B1 (en) | 1997-09-02 | 2001-08-07 | Welfide Corporation | Fused thiophene compounds and medicinal use thereof |
| US6890919B2 (en) * | 2001-06-26 | 2005-05-10 | Shitij Kapur | Atypical antipsychotic agents having low affinity for the D2 receptor |
| US7388954B2 (en) * | 2002-06-24 | 2008-06-17 | Freescale Semiconductor, Inc. | Method and apparatus for tone indication |
| MXPA05005611A (es) * | 2002-11-26 | 2005-07-27 | Alexza Pharmaceuticals Inc | Uso de loxapina y amoxapina para la fabricacion de un medicamento para el tratamiento del dolor. |
| US20050250767A1 (en) * | 2003-01-23 | 2005-11-10 | Weiner David M | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
| NZ541014A (en) * | 2003-01-23 | 2008-05-30 | Acadia Pharm Inc | Use of N-desmethylclozapine to treat schizophrenia while increasing the level of activity of a muscarinic receptor |
| EP1644005B1 (en) * | 2003-07-02 | 2010-08-18 | AstraZeneca AB | Metabolite of quetiapine |
| US20070117789A1 (en) * | 2005-11-18 | 2007-05-24 | Astrazeneca Ab | Method of treatment |
| US20090093460A1 (en) * | 2003-07-02 | 2009-04-09 | Astrazeneca Ab | Compositions |
| US20060252743A1 (en) * | 2005-01-07 | 2006-11-09 | Astrazeneca Ab | Method of treating sleep disorders |
| US20060217365A1 (en) * | 2003-07-02 | 2006-09-28 | Astrazeneca Ab | Method of treating mood disorders |
| US20090093461A1 (en) * | 2003-07-02 | 2009-04-09 | Astrazeneca Ab | Methods of Treating Anxiety and Mood Disorders |
| US20060217367A1 (en) * | 2004-07-01 | 2006-09-28 | Astrazeneca Ab | Method of treating anxiety disorders |
| US20060229292A1 (en) * | 2005-01-07 | 2006-10-12 | Astrazeneca Ab | Method of treating childhood disorders |
| US20060217366A1 (en) * | 2003-07-02 | 2006-09-28 | Astrazeneca Ab | Method of treating schizophrenia and other disorders |
| CN1913900B (zh) * | 2003-12-22 | 2010-11-24 | 阿卡蒂亚药品公司 | 作为毒蕈碱激动剂的氨基取代的二芳基[a,d]环庚烯类似物及神经精神疾病的治疗方法 |
| EP2088147A1 (en) * | 2003-12-22 | 2009-08-12 | Arcadia Pharmaceuticals Inc. | Dibenzo-condensed azepine, diazepine, oxazepine and thiazepine derivatives as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| WO2008021463A2 (en) * | 2006-08-15 | 2008-02-21 | Acadia Pharmaceuticals, Inc. | Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| CA2560671A1 (en) * | 2004-04-01 | 2006-01-05 | Acadia Pharmaceuticals Inc. | Crystalline forms of n-desmethylclozapine |
| BRPI0515518A (pt) * | 2004-09-21 | 2008-07-29 | Hypnion Inc | análogos de loxapina e métodos de usos dos mesmos |
| EP1879569A2 (en) * | 2005-04-22 | 2008-01-23 | Wyeth | Therapeutic combinations for the treatment or prevention of psychotic disorders |
| US20070105836A1 (en) * | 2005-10-31 | 2007-05-10 | Lars Pettersson | Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| SI2307389T1 (sl) | 2008-06-20 | 2013-04-30 | Astrazeneca Ab | Derivat diabenzotiazepina in njegova uporaba |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3107261A (en) * | 1958-11-28 | 1963-10-15 | Bayer Ag | Process for the production of phenyl cyanates and phenyl cyanates |
| NL120551C (nl) * | 1959-09-22 | |||
| US3412193A (en) * | 1965-12-13 | 1968-11-19 | American Cyanamid Co | 11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility |
| AT278805B (de) * | 1966-01-17 | 1970-02-10 | American Cyanamid Co | Verfahren zur herstellung von oxazepinen und thiazepinen |
-
1964
- 1964-05-29 NL NL646406089A patent/NL140242B/nl not_active IP Right Cessation
-
1969
- 1969-02-06 US US797281A patent/US3546226A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US3546226A (en) | 1970-12-08 |
| NL6406089A (nl) | 1964-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL140242B (nl) | Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen. | |
| NL146854B (nl) | Werkwijze voor het bereiden van polyurethankunststoffen. | |
| NL149817B (nl) | Werkwijze ter bereiding van een smeermiddeltoevoegsel. | |
| NL147136B (nl) | Werkwijze voor het bereiden van 3,5-dihalogeen 4-hydroxybenzaldoximederivaten bevattende middelen met een herbicide werking. | |
| NL142747B (nl) | Werkwijze voor het verstevigen van de bodem. | |
| NL139311B (nl) | Werkwijze voor het bereiden van een 2,5-dialkyl 3-hydroxy 4-keto 4,5-dihydrofuran. | |
| NL138953B (nl) | Werkwijze voor de bereiding van een polyamide. | |
| NL155528C (nl) | Werkwijze voor het bereiden van een polyalkyltetraline. | |
| NL144986B (nl) | Werkwijze voor het bereiden van een antibioticum. | |
| NL141586B (nl) | Werkwijze voor het aftrekken van spoelen van de spillen van een ringspin- of ringtwijnmachine. | |
| NL152892B (nl) | Werkwijze voor het bereiden van een copolyamide. | |
| NL139220B (nl) | Werkwijze voor het bereiden van een fungicide. | |
| NL144253B (nl) | Werkwijze voor het bereiden van 2,4,5-trimethylcumeen. | |
| NL144663B (nl) | Werkwijze voor het bereiden van een antibioticum. | |
| NL165448C (nl) | Werkwijze voor het bereiden van een 1,1,1,3,3,3-hexa- halogeenisopropyl-methylether. | |
| NL151053B (nl) | Werkwijze voor de bereiding van cyclododecatrieen-(1,5,9). | |
| NL144180B (nl) | Inspanbus voor het opnemen van een gereedschapsschacht. | |
| NL160151C (nl) | Werkwijze ter bereiding van een preparaat voor het bestrij- den van schadelijke organismen. | |
| NL145873B (nl) | Werkwijze voor het bereiden van een polyamide. | |
| NL6508882A (nl) | Werkwijze voor het bereiden van l-(-)-beta-(3.4-dihydroxy-phenyl)-alpha-methylalanine | |
| NL140517B (nl) | Werkwijze voor het bereiden van een 17 alfa-hydroxy-8,14-secogonatetraeen-14-on. | |
| NL146691B (nl) | Werkwijze voor het bereiden van een preparaat ter bestrijding van micro-organismen. | |
| NL150803B (nl) | Werkwijze voor het bereiden van een ribonycleoside -5'-monofosfaat. | |
| NL149775B (nl) | Werkwijze voor het bereiden van 3,4-dichloorbuteen-1. | |
| NL151345B (nl) | Werkwijze voor het bereiden van alkenisch onverzadigde oxoverbindingen door verhitting van 6,6-dialkyl-5,6-dihydro-4h-pyranen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NL80 | Abbreviated name of patent owner mentioned of already nullified patent |
Owner name: WANDER |
|
| V4 | Discontinued because of reaching the maximum lifetime of a patent |